Customs (Prohibited Imports) Regulations (Amendment)

Overview

This statutory rule, Statutory Rules 1956 No. 40, was enacted under the Customs Act 1901-1954 with the purpose of amending the Customs (Prohibited Imports) Regulations. The regulation was made by the Governor-General in and over the Commonwealth of Australia, acting on the advice of the Federal Executive Council. The specific amendment introduced by this rule adds a new item to the Customs (Prohibited Imports) Regulations, requiring importers of a poliomyelitis vaccine to present an approval to import issued by the Director-General of Health to the Collector of Customs. This legislative instrument aimed to address a gap in the existing regulatory framework concerning the importation of certain medical supplies, specifically the poliomyelitis vaccine, to ensure that such imports meet the necessary health standards and regulatory requirements.

Scope and Application

The Statutory Rules of 1956, No. 40, are a legislative instrument under the Customs Act 1901-1954, serving to amend the Customs (Prohibited Imports) Regulations. This amendment pertains specifically to the importation of Poliomyelitis Vaccine, mandating that importers must present an approval to import issued by the Director-General of Health to the Collector of Customs. This regulation applies to any individual or entity involved in the importation of the Poliomyelitis Vaccine into Australia, ensuring that only those with the necessary health approval can import this item. The amendment extends across the entire Commonwealth of Australia, thereby impacting all states and territories within the country. There are no stated exclusions or exemptions within this particular regulation; it uniformly applies to all entities importing the specified vaccine. The regulation is intended to safeguard public health by controlling the import of medical products, thereby ensuring they meet necessary health standards. This legislative amendment is an example of how subordinate instruments can be used to extend and refine the application of the primary Act.

Key Provisions

The primary operative sections of this legislation (section 1(2)) involve amending the Customs (Prohibited Imports) Regulations by inserting a new item into the Third Schedule. Specifically, item 10aa, titled "Poliomyelitis Vaccine", requires that any importer of such vaccine must produce to the Collector of Customs an approval to import issued by the Director-General of Health. This amendment aims to ensure that the importation of poliomyelitis vaccines is controlled and regulated to protect public health. The Act imposes several obligations on parties involved in the importation of poliomyelitis vaccines. Importers must ensure that they have obtained the necessary approval from the Director-General of Health before attempting to import the vaccine. This requirement is designed to maintain the integrity of the health regulatory framework by ensuring that only approved vaccines enter the country. Additionally, the Collector of Customs is mandated to verify that the importer has the requisite approval document before allowing the vaccine into the country. This verification process is a critical step in enforcing the regulatory requirements set out in the legislation. Failure to comply with the provisions of this legislation can lead to civil and criminal consequences. Importers who fail to produce the required approval from the Director-General of Health may face penalties under the Customs Act 1901-1954. The specific penalties are not detailed in the legislation, but generally, penalties for contravening customs regulations can include fines and potential imprisonment, depending on the severity of the breach. The Collector of Customs is also empowered to seize and detain any prohibited imports, which in this case would be poliomyelitis vaccines imported without the necessary health approval.